Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, WOM

Ava Co-Founder Lea von Bidder Earns Spot on Forbes 30 Under 30 2018 List


SAN FRANCISCO and ZURICH, Nov. 15, 2017 /PRNewswire/ -- Ava, best known as the maker of its popular cycle-tracking Ava bracelet, today announced San Francisco-based co-founder and president Lea von Bidder was named to the annual Forbes "30 Under 30" list for 2018.

Recognized in the Healthcare category, von Bidder, 27, joins an diverse group of men and women on the 2018 Forbes 30 Under 30 List, which features 600 young stars in 20 different industries. Now in its seventh year, Forbes vetted thousands of nominations to create the 2018 list, which describe as "spotlighting the impressive, the inspiring and the (genuinely) enviable."

"This is such an honor for me. For the past three years, I've been working to create and advocate innovations in digital health tech that will empower women to take better control of their health and wellbeing. Being on this list with so many inspiring entrepreneurs gives me hope for the future of femtech, as well as Ava specifically," said von Bidder.

In her role with Ava, von Bidder has helped raise more than $12M in VC funding and expanded product sales through the US and Europe since launching in July 2016. Under her leadership, Ava has garnered coverage among top-tier media outlets including USA Today, Forbes, Wired, the Today Show and the BBC. She's spoken at CES and TechCrunch Disrupt and written several articles on issues related to female entrepreneurs and innovations in digital health for women. Prior to Ava, von Bidder co-founded L'inouï, a premium chocolate company in India. She also worked for the marketing division of Procter & Gamble in Frankfurt and for a strategy-consulting boutique in Paris. Lea holds a Master's degree in global entrepreneurship from EM Lyon in France, Zhejiang University in China and Purdue Krannert University in the USA. She earned her Bachelor's degree from the University of St.Gallen and HEC Montréal.

About Ava

Founded in Switzerland in 2014 by Pascal Koenig, Philipp Tholen, Peter Stein and Lea von Bidder, Ava is a medical technology company dedicated to bringing innovation to women's reproductive health. The Ava bracelet, which received The Bump's "Best of Baby Tech CES 2017" award for fertility and pregnancy, is the company's first consumer product. It uses sensor technology combined with clinically tested data science to precisely detect a woman's entire fertile window in real time. The company is also conducting clinical studies to adapt and expand its algorithms for use in pregnancy monitoring, and future use as a non-hormonal contraceptive device. Backed by $12.3M in seed and Series A funding, Ava has operations in Zurich and San Francisco.

Media Contact:
Lindsay Stevens
[email protected] 
(213) 200-9638

SOURCE Ava


These press releases may also interest you

at 13:22
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...

at 13:05
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...



News published on and distributed by: